TABLE 1.
Bacterial strains and plasmids used in this study
| Strain or plasmid | Relevant characteristic(s) | Source or reference |
|---|---|---|
| Strains | ||
| Bartonella spp. | ||
| B. bacilliformis KC583 | Type strain | 12 |
| B. clarridgeiae | Type strain | 34 |
| B. doshiae R18 | Type strain | 8 |
| B. elizabethae | Type strain | 19 |
| B. grahamii V2 | Type strain | 8 |
| B. henselae Houston R1302 | Type strain | 47 |
| B. quintana OK 90-268 | Human isolate | CDCa |
| B. vinsonii Baker | Vole agent | 69 |
| E. coli | ||
| DH5α | Host strain for cloning | Gibco-BRL |
| XL1-Blue MRF′ | Host strain for λ phage | Stratagene |
| XLOLR | Host strain for pBK-CMV and its derivatives | Stratagene |
| Plasmids | ||
| pBK-CMV | Excised vector from λ Zap | Stratagene |
| pHBP-CMV | pBK-CMV plus 3.5-kbp Sau3AI insert with hbpA | This study |
a
CDC, Centers for Disease Control and Prevention, Atlanta, Ga.